Management of Nerve Sheath Tumors Arising in the Sympathetic Chain

Surbhi Jain, MD; Kristin Houseknecht, MPH; Amyn M. Rojiani, MD, PhD; Matthias Setzer, MD; Frank D. Vrionis, MD, MPH, PhD

Disclosures

Cancer Control. 2008;15(4):352-357.

Study Limitations

This series comprises tumors in different locations that may cause different neurological deficits and functional impairment and may require different surgical techniques and approaches. However, all the tumors belong to the same histologic entity, having presumably the same biological behavior. Given that sympathetic schwannomas are rare, it seems to be justified to include cervical and thoracic tumors in one series.

1 2 3 4 5 6 7

Next Section

Cite this: Management of Nerve Sheath Tumors Arising in the Sympathetic Chain - Medscape - Sep 01, 2008.

Comments

Commenting is limited to medical professionals. To comment please Log-in.

Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.